| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/09/2011 | CA2828041A1 Methods and compositions for treating or preventing symptoms of hormonal variations |
| 09/09/2011 | CA2811091A1 A method for inhibiting alternative pathway mediated disorders with anti-properdin antibodies that inhibit c5 interactions with properdin |
| 09/09/2011 | CA2808233A1 Aptamers to 4-1bb and their use in treating diseases and disorders |
| 09/09/2011 | CA2792161A1 Ep1 inhibition |
| 09/09/2011 | CA2792102A1 Pyrazolopyrimidine derivative |
| 09/09/2011 | CA2792093A1 Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport |
| 09/09/2011 | CA2792090A1 Compositions and methods for treating and/or preventing cardiovascular disease |
| 09/09/2011 | CA2792046A1 Modified release dosage form |
| 09/09/2011 | CA2792036A1 Polymorph of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid |
| 09/09/2011 | CA2792035A1 Compositions and methods for treating or preventing immuno-inflammatory disease |
| 09/09/2011 | CA2792003A1 Compositions comprising myristic acid and uses thereof |
| 09/09/2011 | CA2791974A1 Nucleic acids for targeting multiple regions of the hcv genome |
| 09/09/2011 | CA2791964A1 Isotopically enriched arylsulfonamide ccr3 antagonists |
| 09/09/2011 | CA2791914A1 Nuclear transport modulators and uses thereof |
| 09/09/2011 | CA2791897A1 Sandalwood oil and its uses |
| 09/09/2011 | CA2791884A1 Compositions and methods for treating viral diseases |
| 09/09/2011 | CA2791875A1 Urethanes, ureas, amidines and related inhibitors of factor xa |
| 09/09/2011 | CA2791832A1 Use of meloxicam for the long-term treatment of kidney disorders in cats |
| 09/09/2011 | CA2791805A1 Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
| 09/09/2011 | CA2791738A1 Compounds for treatment of cancer |
| 09/09/2011 | CA2791715A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
| 09/09/2011 | CA2791711A1 Treatment of lupus arthritis using laquinimod |
| 09/09/2011 | CA2791709A1 Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate |
| 09/09/2011 | CA2791691A1 Treatment of lupus nephritis using laquinimod |
| 09/09/2011 | CA2791680A1 Compounds and therapeutic uses thereof |
| 09/09/2011 | CA2791672A1 Positive allosteric modulators of mglur2 |
| 09/09/2011 | CA2791651A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | CA2791630A1 Combination pharmaceutical agents as inhibitors of hcv replication |
| 09/09/2011 | CA2791561A1 Dabigatran etexilate-containing oral pharmaceutical composition |
| 09/09/2011 | CA2791535A1 Methods and systems for preparing irreversible inhibitors of protein tyrosine phosphatases |
| 09/09/2011 | CA2791526A1 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
| 09/09/2011 | CA2791490A1 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same |
| 09/09/2011 | CA2791482A1 Ketobenzofuran derivatives, method for synthesising same, and intermediates |
| 09/09/2011 | CA2791457A1 Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders |
| 09/09/2011 | CA2791448A1 Biocidal composition and method |
| 09/09/2011 | CA2791431A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 09/09/2011 | CA2791426A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 09/09/2011 | CA2791338A1 Heterocyclic amides as rock inhibitors |
| 09/09/2011 | CA2791327A1 Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms |
| 09/09/2011 | CA2791300A1 6-benzylphenyl-2-sulfurterahydropyran-3,4,5-triol derivatives as inhibitors of sodium-glucose cotransporters 1 and 2 for use in diabetic patients |
| 09/09/2011 | CA2791174A1 Alkylamine derivative |
| 09/09/2011 | CA2791050A1 Threads of cross-linked hyaluronic acid and methods of use thereof |
| 09/09/2011 | CA2791009A1 Use of riluzole to treat or prevent the adverse effects of antineoplastic agents |
| 09/09/2011 | CA2790869A1 A3ar agonists for the treatment of uveitis |
| 09/09/2011 | CA2790707A1 Fluorouracil derivatives |
| 09/09/2011 | CA2790682A1 Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
| 09/09/2011 | CA2790654A1 Novel pharmaceutical composition for the treatment of neurodegenerative or neurovascular diseases |
| 09/09/2011 | CA2790060A1 Compounds useful for treating neurodegenerative disorders |
| 09/09/2011 | CA2789480A1 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| 09/09/2011 | CA2789475A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 09/09/2011 | CA2789474A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 09/09/2011 | CA2789471A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 09/09/2011 | CA2787123A1 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect |
| 09/09/2011 | CA2784819A1 Method of treating parkinson's disease |
| 09/09/2011 | CA2754839A1 Pharmaceutical composition comprising levamlodipine and chlorthalidone |
| 09/08/2011 | US20110218506 Amorolfine patch for the treatment of onychomycosis |
| 09/08/2011 | US20110218482 Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin |
| 09/08/2011 | US20110218343 Small molecule inhibitors of rotamase enzyme activity |
| 09/08/2011 | US20110218250 Composition based on glycerol ether/polyol mixtures |
| 09/08/2011 | US20110218249 Use of hypericum perforatum extracts in the treatment of neuropathic pain |
| 09/08/2011 | US20110218248 Organic compounds |
| 09/08/2011 | US20110218247 Formulations of low dose diclofenac and beta-cyclodextrin |
| 09/08/2011 | US20110218246 Methods of treating non-nociceptive pain states with gastric retentive gabapentin |
| 09/08/2011 | US20110218245 Use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them |
| 09/08/2011 | US20110218244 CREATINE ß-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE |
| 09/08/2011 | US20110218243 Compositions and methods for treating and/or preventing cardiovascular disease |
| 09/08/2011 | US20110218242 Polyunsaturated Fatty Acids for Treatment of Dementia and Pre-Dementia-Related Conditions |
| 09/08/2011 | US20110218241 Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts |
| 09/08/2011 | US20110218240 Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same |
| 09/08/2011 | US20110218239 Use of 5,6-Dimethylxanthenone-4-Acetic Acid as an Antiviral Agent |
| 09/08/2011 | US20110218238 Compounds, compositions, formulations and their uses thereof |
| 09/08/2011 | US20110218237 Compound and composition and their uses thereof |
| 09/08/2011 | US20110218236 Compound and composition and their uses thereof |
| 09/08/2011 | US20110218235 Compound and composition and their uses thereof |
| 09/08/2011 | US20110218234 Gene vector for inducing transgene-specific immune tolerance |
| 09/08/2011 | US20110218233 Treatment of scleroderma |
| 09/08/2011 | US20110218232 Inhibitors of MRP4 and Agents Stimulating MRP4 Activity for the Treatment of Cardiac Disorders |
| 09/08/2011 | US20110218231 Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases |
| 09/08/2011 | US20110218230 Natriuretic peptide related fragment in cardiovascular disease |
| 09/08/2011 | US20110218229 SIRT1 Modulation of Adipogenesis and Adipose Function |
| 09/08/2011 | US20110218228 Crystalline sodium atorvastatin |
| 09/08/2011 | US20110218227 Hydrate crystals |
| 09/08/2011 | US20110218226 Anti-virulence compositions and methods |
| 09/08/2011 | US20110218225 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
| 09/08/2011 | US20110218224 Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof |
| 09/08/2011 | US20110218223 Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 09/08/2011 | US20110218222 Neurorestoration with r(+) pramipexole |
| 09/08/2011 | US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof |
| 09/08/2011 | US20110218220 Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution |
| 09/08/2011 | US20110218219 Substituted sulphonamido phenoxybenzamides |
| 09/08/2011 | US20110218218 Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain |
| 09/08/2011 | US20110218217 Piperidylpropionamide derivatives useful for the treatment of cns disorders including depression and panic disorder |
| 09/08/2011 | US20110218216 Extended release pharmaceutical composition of donepezil |
| 09/08/2011 | US20110218215 Compositions and Methods for Treating Social Anxiety |
| 09/08/2011 | US20110218214 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 09/08/2011 | US20110218213 Methods and Compositions for Treating or Preventing Symptoms of Hormonal Variations |
| 09/08/2011 | US20110218212 Predictive markers for egfr inhibitors treatment |
| 09/08/2011 | US20110218211 Azaindole inhibitors of iap |
| 09/08/2011 | US20110218210 Compounds for treating abnormal cellular proliferation |
| 09/08/2011 | US20110218209 Nutrient delievry drug composition |